Page last updated: 2024-12-06
2-chlorodibenzo-4-dioxin
Description
2-chlorodibenzo-4-dioxin is a polychlorinated dibenzodioxin (PCDD) compound. PCDDs are a class of highly toxic and persistent environmental pollutants that have been linked to various adverse health effects in humans and animals. 2-chlorodibenzo-4-dioxin is specifically known for its potential to disrupt endocrine function and cause developmental abnormalities. It is a by-product of industrial processes such as waste incineration and chemical manufacturing. The compound's environmental persistence and potential for bioaccumulation in food chains make it a significant concern for human health and the environment. Research into 2-chlorodibenzo-4-dioxin focuses on understanding its formation pathways, environmental fate, and biological effects to develop strategies for minimizing its production and exposure. It is studied to assess its toxicity and develop methods for its remediation.'
2-chlorodibenzo-4-dioxin: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 38252 |
SCHEMBL ID | 1690731 |
MeSH ID | M0089671 |
Synonyms (23)
Synonym |
dibenzo[b,e][1,4]dioxin, 2-chloro- |
2-chloro-dibenzo[b,e][1,4]dioxin |
2-chlorodibenzo-p-dioxin |
2-mcdd |
dibenzo(b,e)(1,4)dioxin, 2-chloro- |
2-monochlorodibenzo-p-dioxin |
dibenzo-p-dioxin, 2-chloro- |
brn 0176668 |
2-chlorodibenzo-para-dioxin |
2-chlorodibenzo-4-dioxin |
2-chlorooxanthrene |
STK020583 |
AKOS005378874 |
n0ssv5ygwh , |
unii-n0ssv5ygwh |
39227-54-8 |
pcdd 2 |
SCHEMBL1690731 |
2-chlorooxanthrene # |
GIUGGRUEPHPVNR-UHFFFAOYSA-N |
DTXSID90192488 |
2-chlorodibenzo[b,e][1,4]dioxine |
Q27284358 |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.59
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.59 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.54 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |